The European Chemicals Agency (ECHA) will virtually hold the 10th Meeting of the Committee for Risk Assessment (RAC) Working Group on Harmonised Classification and Labelling (RAC-66 CLHWG) from 3 to 5 July 2023. This meeting will be an opportunity to discuss the following CLH dossiers: Clopyralid (ISO); 3,6-dichloropyridine-2-carboxylic acid (EC: 216-935-4; CAS: 1702-17-6) 2-bromo-3,3,3-trifluoroprop-1-ene (EC: -; CAS: 1514-82-5) 2,3-epoxypropyl o-tolyl…
Read More
ECHA has published their latest weekly update (17 May). Due to changes in the structure of ECHA's updates, we can no longer link to updates themselves. To ensure BIVDA members continue to receive this information, we have opted to provide the full ECHA notification. Follow our new approach methodologies workshop online On 31 May and 1 June 2023, we…
Read More
On May 08, 2023, the Commission launched an open public consultation as part of an initiative to prohibit the production for export of hazardous chemicals that are banned in the EU. The consultation is open until 31 July. The initiative is a commitment made under the Chemicals Strategy for Sustainability, which is part of the Green Deal’s ambition for a toxic-free…
Read More
On 20 April, ECHA opened the second Call for Evidence Consultation for the substance 1,4-dioxane (EC: 204-661-8; CAS: 123-91-1), and its restriction proposal. This substance is registered under the REACH Regulation. 1,4-dioxane substance information card can be found here. We encourage you to submit any evidence to this consultation where your organisation uses this substance. The consultation will close on…
Read More
ECHA has published their latest weekly update (10 May). Due to changes in the structure of ECHA's updates, we can no longer link to updates themselves. To ensure BIVDA members continue to receive this information, we have opted to provide the full ECHA notification. ECHA Conference 2024 – save the date and share your ideas The next ECHA Conference…
Read More
The Scientific Committee on Health, Environmental and Emerging Risks (SCHEER) has received a request for updating the guidelines on the benefit-risk assessment of the presence of phthalates in certain medical device covering phthalates which are carcinogenic, mutagenic, toxic to reproduction (CMR) or have endocrine-disrupting properties. To ensure all relevant scientific information is available to the Scientific Committee for its assessment,…
Read More
ECHA has published their latest weekly update (3 May). Due to changes in the structure of ECHA's updates, we can no longer link to updates themselves. To ensure BIVDA members continue to receive this information, we have opted to provide the full ECHA notification. Info session on PFAS restriction proposal: first Q&As now online The first batch of questions…
Read More
Recently, BIVDA joined the Joint Trade Association, a collective of Trade Associations in the electronic space. This is in response to ongoing pressure with UK RoHS and the new fee associated with submitting applications of exemption under UK RoHS. We hope that by working with JTA, we will be able to support the BIVDA membership in submitting, or collating, UK…
Read More
ECHA has published their latest weekly update (26 April). Due to changes in the structure of ECHA's updates, we can no longer link to updates themselves. To ensure BIVDA members continue to receive this information, we have opted to provide the full ECHA notification. ECHA provides advice on new hazard classes for substances and mixtures Three new hazard classes…
Read More
MedTech Europe have previously requested information on mercury lamps used in the medical device and IVD sectors. It was noted previously that under RoHS exemption 1(f)-II and 2(b)4-I for neonatal jaundice treatment, we have no uses of mercury lamps in these exemptions. Further information has been requested by LightingEurope as to the reason for this, primarily whether this is due…
Read More
The restriction proposal for D4/D5/D6 is expected to be discussed within REACH Committees in June 2023. ECHA has proposed derogations for medical technologies, including for certain uses or increased allowable concentrations: Dental impression materials Medical devices for scar and wound management, and stoma care More information can be found on the Silicones Europe website. This information was kindly provided…
Read More
ECHA has published their latest weekly update (12 April). Due to changes in the structure of ECHA's updates, we can no longer link to updates themselves. To ensure BIVDA members continue to receive this information, we have opted to provide the full ECHA notification. Watch our webinar on ECHA's new public data availability system The recording and presentations from our…
Read More
ECHA has proposed to include lead metal under REACH Annex XIV. This proposal excludes the use of glutaral in laboratory reagents in scientific research and development, use in medical devices, and formulation in biocidal products. Members are requested to review the proposal and inform Ashleigh (ashleigh@bivda.org.uk) by 26 April or any concerns affecting your organisation from this proposal. This…
Read More
ECHA has proposed to include lead metal under REACH Annex XIV. A few examples of the uses in scope of the proposed Authorisation are: batteries, ammunition, cables, vehicles, machinery, electronics, radiation shielding, sanitary, construction, art and musical instruments. Members are requested to review the proposal and inform Ashleigh (ashleigh@bivda.org.uk) by 26 April if there are any uses that would fall…
Read More
ECHA has published their latest weekly update (12 April). Due to changes in the structure of ECHA's updates, we can no longer link to updates themselves. To ensure BIVDA members continue to receive this information, we have opted to provide the full ECHA notification. ECHA recommends eight substances for REACH authorisation To protect workers and the environment, we recommend that…
Read More
